Specialty Chemicals company Fineotex Chemical announced H1FY25 & Q2FY25 results Q2FY25 Financial Highlights: Standalone: Revenue from Operation for the Quarter has increased to ~ Rs 11,536 lakh from ~ Rs 10,661 lakh i.e., a growth of 8.21% QoQ. The Profit after tax (PAT) has increased to ~Rs. 3,145 lakh from ~ Rs 2,185 lakh i.e., a growth of 43.94% QoQ. The Operational EBITDA has increased to ~Rs. 2,971 lakh from ~Rs. 2,618 lakh i.e., a growth of 13.48% QoQ. Consolidated: Revenue from Operation for the Quarter has increased to ~ Rs 14,573 lakh from ~ Rs 14,190 lakh i.e., a growth of 2.70% QoQ. The Profit after tax (PAT) has increased to ~Rs. 3,207 lakh from ~ Rs 2,918 lakh i.e., a growth of 9.90% QoQ. H1FY25 Financial Highlights: Standalone: Revenue from Operation for the half year has increased to ~ Rs 22,197 lakh from ~ Rs 19,253 lakh i.e., a growth of 15.29% YoY. The Profit after tax (PAT) has increased to ~Rs. 5,330 lakh from ~ Rs 5,000 lakh i.e., a growth of 6.60% YoY. The Operational EBITDA has increased to ~Rs. 5,589 lakh from ~Rs. 5,022 lakh i.e., a growth of 11.29% YoY. Consolidated: Revenue from Operation for the half year has increased to ~ Rs 28,763 lakh from ~ Rs 27,750 lakh i.e., a growth of 3.65% YoY. The Profit after tax (PAT) has increased to ~Rs. 6,125 lakh from ~ Rs 5,762 lakh i.e., a growth of 6.30% YoY. Other Highlights: We have completed successful fund raise of Rs 218.11 crore through Preferential Allotment of Equity Shares and Convertible Warrants at a price of Rs 387.40/- with a total fund raise of Rs 342.55/- crore during this financial year upto 30th September 2024. The Nomination and Remuneration Committee at its meeting held on November 13, 2024, has considered and approved the Allotment of 25,052 Equity Shares pursuant to exercise of vested Employee Stock Options under the Fineotex Chemical Limited - Employee Stock Option Plan 2020 ("FCL-ESOP 2020”). The company has granted an ESOP to 110 Employees upto 30th September 2024. Result PDF